Ni Xin
倪鑫
Chief Physician, Professor, Doctoral Supervisor; President of Beijing Children's Hospital
Pediatric head and neck surgery, head and neck tumors, and pediatric solid-tumor systems research, with documented relevance to neuroblastoma, rhabdomyosarcoma, and hepatoblastoma(小儿耳鼻咽喉头颈外科、头颈肿瘤，以及与神经母细胞瘤、横纹肌肉瘤、肝母细胞瘤相关的儿童实体肿瘤临床与体系研究)
10,000+ career cases
(bch.com.cn)Leadership & Positions
- President, Beijing Children's Hospital
- Director, National Children's Medical Center
- Director, National Children's Tumor Monitoring Center
- Director, Beijing Pediatric Research Institute
- Dean, School of Pediatrics, Capital Medical University
- President, Pediatric Surgeons Branch, Chinese Medical Doctor Association
- Former Chair, Pediatric Surgery Branch, Chinese Medical Association
Notable Publications
Socioeconomic inequalities in cancer survival and access to health care among children and adolescents in China, 2018–24: a prospective nationwide cohort study
The Lancet (2025) — first author | corresponding author
Spatial and Single Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor-Ligand Interactions that Instructs Intratumoral γδT-Cell Activity
Cancer Research (2025) — corresponding author
Risk Factors for Survival in Pediatric Maxillofacial Rhabdomyosarcoma: A Single-Center Retrospective Cohort Study.
Journal of Oral and Maxillofacial Surgery (2026) — co-author
PubMed/DOIPioneering Contributions
- Built China's national pediatric tumor monitoring system and, according to the official Beijing Children's Hospital-affiliated report, established 1,760 pediatric tumor surveillance sites nationwide.
- Led development of the Chinese diagnostic and treatment framework for pediatric solid tumors, with the Beijing Children's Hospital-affiliated report crediting him with helping formulate 29 guidelines, standards, or expert consensuses for Chinese pediatric solid tumors.
- Leads a pediatric head and neck tumor multidisciplinary team at Beijing Children's Hospital and the official physician page states he has completed more than 10,000 complex operations, with extensive experience in neuroblastoma and rhabdomyosarcoma-related care within head and neck practice.
Sources — Ni Xin
- https://www.bch.com.cn/Html/Doctors/Main/Index_372.html—Official identity verification, current department, title, hospital affiliation, social roles, pediatric oncology relevance, headshot, and cumulative difficult-surgery volume over 10,000(accessed Apr 16, 2026)
- https://news.ccmu.edu.cn/syyw_12977/1e40a50c3c804e81ad44b7f1c46a4bd3.htm—Official oncology leadership roles, Lancet pediatric cancer survival study, and authorship details(accessed Apr 16, 2026)
- https://news.ccmu.edu.cn/syyw_12977/c629b06ecf8b4abaaf3352cca6a56a3c.htm—Official neuroblastoma tumor-microenvironment research article, Cancer Research paper title, and corresponding-author role(accessed Apr 16, 2026)
- https://www.bch-syfy.cn/Html/News/Articles/11087.html—Official affiliated-hospital profile describing pediatric tumor surveillance system, 1,760 monitoring sites, pediatric solid-tumor standards work, and broader oncology innovation contributions(accessed Apr 16, 2026)
- https://www.haodf.com/doctor/1743/xinxi-jieshao.html—Secondary confirmation of ENT/head-neck tumor focus, surgery volume narrative, and current institutional roles(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/41942067/—Publication verification for pediatric maxillofacial rhabdomyosarcoma study(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/40835926/—Publication verification for neuroblastoma immune-function study relevant to subspecialty focus(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/40204725/—Publication verification for hepatoblastoma research relevant to pediatric solid-tumor focus(accessed Apr 16, 2026)